SOLID BIOSCIENCES INC's ticker is SLDB and the CUSIP is 83422E105. A total of 78 filers reported holding SOLID BIOSCIENCES INC in Q4 2020. The put-call ratio across all filers is 0.37 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $0 | -100.0% | 491 | -97.8% | 0.00% | – |
Q1 2022 | $27,000 | -30.8% | 22,491 | 0.0% | 0.00% | – |
Q4 2021 | $39,000 | -27.8% | 22,491 | -0.5% | 0.00% | – |
Q3 2021 | $54,000 | -71.1% | 22,611 | -55.9% | 0.00% | – |
Q2 2021 | $187,000 | +114.9% | 51,223 | +224.2% | 0.00% | – |
Q1 2021 | $87,000 | -27.5% | 15,800 | 0.0% | 0.00% | – |
Q4 2020 | $120,000 | +275.0% | 15,800 | 0.0% | 0.00% | – |
Q3 2020 | $32,000 | -30.4% | 15,800 | 0.0% | 0.00% | – |
Q2 2020 | $46,000 | +21.1% | 15,800 | 0.0% | 0.00% | – |
Q1 2020 | $38,000 | -45.7% | 15,800 | 0.0% | 0.00% | – |
Q4 2019 | $70,000 | -57.1% | 15,800 | 0.0% | 0.00% | – |
Q3 2019 | $163,000 | +526.9% | 15,800 | +243.5% | 0.00% | – |
Q2 2019 | $26,000 | -38.1% | 4,600 | 0.0% | 0.00% | – |
Q1 2019 | $42,000 | -88.4% | 4,600 | -65.9% | 0.00% | -100.0% |
Q4 2018 | $362,000 | -26.9% | 13,500 | +28.6% | 0.00% | 0.0% |
Q3 2018 | $495,000 | +32.4% | 10,500 | 0.0% | 0.00% | – |
Q2 2018 | $374,000 | +373.4% | 10,500 | 0.0% | 0.00% | – |
Q1 2018 | $79,000 | – | 10,500 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Bain Capital Life Sciences Investors, LLC | 7,929,918 | $13,877,000 | 1.10% |
EcoR1 Capital, LLC | 9,202,702 | $16,105,000 | 0.51% |
RA Capital Management | 12,367,873 | $21,644,000 | 0.38% |
Perceptive Advisors | 26,825,104 | $46,944,000 | 0.36% |
Boxer Capital, LLC | 3,177,702 | $5,561,000 | 0.22% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 6,287,193 | $11,003,000 | 0.21% |
Artal Group S.A. | 3,000,000 | $5,250,000 | 0.14% |
Ikarian Capital, LLC | 521,155 | $911,000 | 0.14% |
CAXTON ASSOCIATES LP | 177,571 | $311,000 | 0.03% |
ALGERT GLOBAL LLC | 136,138 | $238,000 | 0.03% |